Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07356973
Recruiting
Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma
Phase 2 · United Kingdom · 1 site
Registry update: 3 Sept 2026
NCT07674667
Recruiting
FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS
Phase 1/2 · Germany, United Kingdom, Netherlands · 6 sites
Registry update: 14 Oct 2026
NCT07612527
Recruiting
Bariatric Endoscopic Antral Myotomy Combined With Fundal Gastric Mucosal Ablation
Phase 2 · Egypt · 1 site
Registry update: 21 Aug 2026
NCT07071532
Recruiting
A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar Disorder
Phase 1 · United States · 2 sites
Registry update: 16 Sept 2026
NCT07784894
Recruiting
A Study to Investigate the Repeat-dose Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With Ganfeborole in Female Participants of Non-childbearing Potential
Phase 1 · Spain · 1 site
Registry update: 2 Oct 2026
2026-525790-39-00
Recruiting
A study to investigate the repeat-dose pharmacokinetics of a combined oral contraceptive when given alone and in combination with ganfeborole in female participants of non-childbearing potential.
Phase 1 · Spain · 1 site
Registry update: 7 Oct 2026
NCT07857200
Recruiting
The Use of Risk Prediction to Identify Patients at Risk for Chronic Kidney Disease: Patient and Provider Interventions for Patients at High Risk for Chronic Kidney Disease
Not applicable · United States · 1 site
Registry update: 5 Oct 2026
2025-525105-20-00
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax (ABBV-453) Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Phase 1/2 · Belgium, Czechia, Germany, France, Greece, Italy, Poland, Portugal, Sweden · 33 sites
Registry update: 15 Jul 2026
NCT07788625
Recruiting
¹⁸F-PSMA-1007 PET-CT-Directed Focal Therapy for MRI-Invisible Prostate Cancer
Not applicable · Hong Kong · 1 site
Registry update: 26 Aug 2026
NCT07406685
Recruiting
The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation
Phase 4 · Taiwan · 1 site
Registry update: 25 Aug 2026
NCT07749768
Recruiting
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis
Phase 1 · United States · 1 site
Registry update: 9 Sept 2026
NCT07784725
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Phase 3 · Argentina, Australia, Bulgaria, Brazil, Canada, China, Czechia, Germany, France, India, Italy, Japan, South Korea, Poland, Taiwan, United States · 216 sites
Registry update: 30 Oct 2026
NCT07118059
Recruiting
Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial
Phase 2 · South Africa · 1 site
Registry update: 9 Sept 2026
NCT07812805
Recruiting
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
Phase 1 · South Korea, United States · 5 sites
Registry update: 10 Sept 2026
NCT07864025
Recruiting
Identification of Lesion Characteristics in Coronary Plaques Using Multimodality Intravascular Imaging and Novel Photon-counting CT in Stable Angina
Not applicable · United Kingdom · 1 site
Registry update: 7 Oct 2026
NCT07143448
Recruiting
A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
Phase 1/2 · Spain, United Kingdom, United States · 7 sites
Registry update: 30 Oct 2026
NCT07559929
Recruiting
A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer.
Phase 1/2 · China · 1 site
Registry update: 24 Sept 2026
NCT07657806
Recruiting
DEC003M in Prostate Cancer
Phase 1 · China · 7 sites
Registry update: 14 Oct 2026
2025-523892-50-00
Recruiting
A Randomized Open Label Trial Exploring the Soluble and Imaging Biomarker Dynamic Responses to Tolebrutinib Compared to Rituximab Treatment in Patients with Multiple Sclerosis (MS)
Phase 3 · Sweden · 1 site
Registry update: 2 Jun 2026
NCT07667829
Recruiting
Vasopressor Agents in Pulmonary Hypertension Crisis
Not applicable · China · 3 sites
Registry update: 30 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.